Clinical Trial Update: A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy [Phase 2]

View source ↗

Summary

A single-arm Phase II trial evaluating aspirin for prevention of venous thromboembolism in patients with advanced germ cell tumors receiving chemotherapy; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Testicular Cancer

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Germ Cell Tumor, Testicular Cancer | Phase 2 | Status: RECRUITING